A PET imaging probe developed by Massachusetts General Hospital (MGH) investigators appears able to diagnose and stage pulmonary fibrosis—an often life-shortening lung disease—as well as monitor the response to treatment. ...
Apr 5, 2017
0
55
Overuse injuries—think muscle strains, tennis elbow, and rotator cuff tears—are a considerable problem in the United States, especially among young athletes. But while commonly associated with sports, overuse injuries—particularly ...
Mar 30, 2020
0
6
People with a lung scarring condition that leaves them fighting for breath could be helped by a new medication, research suggests.
May 18, 2017
0
127
Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.
Aug 23, 2021
0
613
Stanford Medicine researchers have found a mechanism behind one of the most common symptoms of long COVID—shortness of breath. Post COVID-19 breathing problems are caused by a condition known as lung fibrosis, when damaged ...
Mar 20, 2023
0
129
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
Dec 8, 2020
0
10
Scientists searching for a therapy to stop the deadly and mostly untreatable lung disease, idiopathic pulmonary fibrosis (IPF), found a new molecular target that slows or stops the illness in preclinical laboratory tests.
Apr 10, 2018
0
46
First there was the "heart in a box," a revolutionary experimental technology that allows donor hearts to be delivered to transplant recipients warm and beating rather than frozen in an ice cooler.
Nov 26, 2012
0
0
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease caused by progressive scarring of the lungs, leading to respiratory failure and death. Therapies to treat IPF are limited, making studies on the mechanisms ...
Jul 25, 2022
0
91
An invasive cell that leads to fibrosis of the lungs may be stopped by cutting off its supply of sugar, according to researchers at Duke University Medical Center.
Jun 27, 2011
0
1
